Frequencies below are aligned with the Mysimba SmPC categories
The regulatory timeline, however, is slow: an NDA is expected in Q4 2026, FDA approval not before late 2027, and a commercial launch around 2028
10.1186/s13287-018-0794-4 28 DumasiaN
In oncology, a 2026 meta-analysis quantified this mismatch directly: Black cancer patients had an enrollment-to-incidence ratio of just 0.25 and Hispanic patients 0.51 , meaning both groups enroll in trials at roughly a quarter to a half of the rate their cancer incidence would predict ( [12] )
The two work through different mechanisms that combine for a stronger GH pulse
Additionally, because this antioxidant protects your cells from free radicals, it reduces the effects of oxidative stress on your skin, which appears as fine lines, wrinkles, and sagging skin